Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Ingenia Therapeutics Inc. (KOSDAQ:950260)
South Korea
· Delayed Price · Currency is KRW
Full Chart
Watchlist
Alerts
Compare
18,000
+650 (3.75%)
At close: Aug 28, 2026
Overview
Financials
Statistics
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Quarterly
TTM
Ingenia Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
TTM
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Mar '26
Mar 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Cash & Equivalents
3,070
5,791
1,203
Short-Term Investments
746.2
5,450
2,996
Trading Asset Securities
5,082
8,122
33,012
Cash & Short-Term Investments
8,899
19,362
37,211
Cash Growth
-
-47.97%
-
Receivables
-
-
735
Prepaid Expenses
-
1,655
2,116
Other Current Assets
3,342
2,044
-0
Total Current Assets
12,240
23,061
40,062
Property, Plant & Equipment
2,906
2,586
2,881
Long-Term Investments
6,043
1,413
6,462
Other Intangible Assets
635.98
608.92
648.12
Other Long-Term Assets
1,103
1,603
5,665
Total Assets
22,929
29,273
55,717
Liabilities
TTM
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Mar '26
Mar 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Accrued Expenses
-
34.25
87.88
Current Portion of Leases
986.45
928.53
923.47
Current Income Taxes Payable
-
0.81
2,361
Other Current Liabilities
7,519
7,743
5,262
Total Current Liabilities
8,506
8,707
8,634
Long-Term Leases
705.45
883.07
1,714
Other Long-Term Liabilities
77.98
73.29
72.49
Total Liabilities
9,289
9,663
10,420
Shareholders' Equity
TTM
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Mar '26
Mar 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Common Stock
5.24
0.81
0.52
Additional Paid-In Capital
43,830
41,556
40,449
Retained Earnings
-33,239
-24,288
2,455
Comprehensive Income & Other
3,044
2,336
2,388
Total Common Equity
13,640
19,606
45,293
Shareholders' Equity
13,640
19,610
45,297
Total Liabilities & Equity
22,929
29,273
55,717
Additional Metrics
TTM
Mil
Millions
Data
Data Source
KRW
KRW
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Mar '26
Mar 31, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Total Debt
1,692
1,812
2,637
Net Cash (Debt)
7,207
17,551
34,573
Net Cash Growth
-
-49.24%
-
Net Cash Per Share
346.60
1292.66
813.67
Filing Date Shares Outstanding
44.19
44.19
12.19
Total Common Shares Outstanding
44.19
44.19
12.19
Working Capital
3,735
14,354
31,428
Book Value Per Share
308.67
443.67
3714.94
Tangible Book Value
13,004
18,997
44,644
Tangible Book Value Per Share
294.28
429.89
3661.78
Machinery
1,891
1,359
529.59
Construction In Progress
8.03
-
51.72